Description:
Syrosingopine is a dual MCT1 and MCT4 inhibitor. Syrosingopine sensitizes cancer cells to metformin, which can be a promising therapeutic strategy for clinical application for the treatment of cancer.
- Molecular Weight:666.72
- Boiling Point:795°C at 760 mmHg
- Melting Point:175°C
Molecular Formula:
C35H42N2O11
Canonical SMILES:
O=C(OC1=C(OC)C=C(C=C1OC)C(=O)OC2CC3CN4CCC=5C=6C=CC(OC)=CC6NC5C4CC3C(C(=O)OC)C2OC)OCC
InChI:
InChI=1S/C35H42N2O11/c1-7-46-35(40)48-31-26(42-3)12-18(13-27(31)43-4)33(38)47-28-14-19-17-37-11-10-22-21-9-8-20(41-2)15-24(21)36-30(22)25(37)16-23(19)29(32(28)44-5)34(39)45-6/h8-9,12-13,15,19,23,25,28-29,32,36H,7,10-11,14,16-17H2,1-6H3
InChIKey:
ZCDNRPPFBQDQHR-UHFFFAOYSA-N
Solubility:
Chloroform (Slightly), Methanol (Slightly)
Storage: Hygroscopic, -20°C Freezer, Under inert atmosphere
Synonyms:
Syringopine; Menatensina; Neoreserpan Weitere Informationen finden Sie
hier